ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

March 7, 2003

Tobacco Council awards $10 Million In 1986

August 14, 1987

Waksals Keep ImClone Jobs, BMS Pumps $200M Into C225

March 8, 2002

Early ADT Doesn’t Offer Survival Advantage—ASCO

April 27, 2007

Vanderbilt Wins Lung Cancer SPORE Grant.

May 18, 2001

NCI Halts Routine P01 Site Visits Due to Travel Cut

February 7, 1992